A2 Milk could benefit as Abbott pulls out of Chinese infant formula market

A2 Milk could benefit as Abbott pulls out of Chinese infant formula market
The US company's market share in China will be up for grabs. (Image: Getty)
Rebecca Howard
A2 Milk stands to benefit as US-based healthcare firm Abbott Laboratories phases out its infant and child nutrition business in China, but the news also underscores how tough that market is.Abbott will gradually stop making and selling baby formula under the Eleva, PediaSure, and Similac brands as well as the sub-brands of Total Comfort and NeoSure, it said on WeChat, according to news service Yicai Global.In the English translation of an internal email seen by BusinessDesk, company executives said it was a “difficult decision” that...

More Primary Sector

Lactalis-owned NZ New Milk restructures operations
Primary Sector

Lactalis-owned NZ New Milk restructures operations

French company set to become the new owner of Mainland Group.

Riley Kennedy 12 Sep 2025
Miraka’s rapid sale illustrates David/Goliath dairy battle
Primary Sector

Miraka’s rapid sale illustrates David/Goliath dairy battle

Open Country’s buyout cements its place as NZ’s clear No 2 dairy processor.

Riley Kennedy 05 Sep 2025